Tenoxicam

Tenoxicam
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Oral
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • UK: POM (Prescription only)
Pharmacokinetic data
Protein bindingHigh
Elimination half-life30–140 hours
Identifiers
  • (3E)-3-[hydroxy(pyridin-2-ylamino)methylene] -2-methyl-2,3-dihydro-4H-thieno[2,3-e] [1,2]thiazin-4-one 1,1-dioxide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
CompTox Dashboard (EPA)
ECHA InfoCard100.149.365 Edit this at Wikidata
Chemical and physical data
FormulaC13H11N3O4S2
Molar mass337.37 g·mol−1
Melting point209 to 213 °C (408 to 415 °F) (dec.)
 ☒NcheckY (what is this?)  (verify)

Tenoxicam, sold under the brand name Mobiflex among others, is a nonsteroidal anti-inflammatory drug (NSAID). It is used to relieve inflammation, swelling, stiffness, and pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis (a type of arthritis involving the spine), tendinitis (inflammation of a tendon), bursitis (inflammation of a bursa, a fluid-filled sac located around joints and near the bones), and periarthritis of the shoulders or hips (inflammation of tissues surrounding these joints).[1]

Tenoxicam belongs to the class of NSAIDs known as oxicams.

It was patented in 1974 by Roche and approved for medical use in 1987.[2] It is available as a prescription-only drug in the United Kingdom and other countries, but not in the US. Outside the United Kingdom, tenoxicam is also marketed under brand names including Tilatil, Tilcitin, and Alganex.[1][3]

  1. ^ a b "Medicines A-Z - Tenoxicam". NHS. Retrieved July 3, 2015.
  2. ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 519. ISBN 9783527607495.
  3. ^ "Drugs.com international listings for Tenoxicam". Drugs.com. Retrieved July 3, 2015.